BRIAN GIBSON: Open Payments
NPI 1427337765 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 14 payments from 6 companies in 2025. Trend: 2023 $164 · 2024 $261 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $259 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| Medtronic, Inc. | 2 | $47 |
| ABIOMED | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: AIRSUPRA, BREZTRI, LEQVIO, MICRA, ELIQUIS, CAMZYOS, NUCALA.
Industry payments across MS — which companies pay providers there.
